Researcher.Life Logo

Oncolog-Hematolog.ro : Impact Factor & More

eISSN: 2066-8260pISSN: 2066-8716
JournalOpen Access
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Oncolog-Hematolog.ro

Oncolog-Hematolog.ro Journal Specifications

Overview
Publisher Medichub Media
Language English
Publication Time8
Editorial Review ProcessPeer review
General Details
LanguageEnglish
Society/Institute/SponsorRomanian Society of Radiotherapy and Medical Oncology
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 8
Editorial Review Detail
Editorial TeamVisit website
Review ProcessPeer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
License typeCC BY
OA statementVisit website
View less

Planning to publish in Oncolog-Hematolog.ro ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Oncolog-Hematolog.ro

Renal cancer: from biological heterogeneity to clinical decision-making
  • 1 Jan 2026
  • Oncolog-Hematolog.ro
Redefining the timing of palliative care initiation in advanced and metastatic cancer: from prognostic thresholds to needs-based concurrent integration along the therapeutic trajectory
  • 1 Jan 2026
  • Oncolog-Hematolog.ro
Application of CRISPR-Cas9 technology in the treatment of chronic lymphocytic leukemia with P53 gene mutations
  • 1 Jan 2026
  • Oncolog-Hematolog.ro
Title not available
  • 1 Jan 2025
  • Oncolog-Hematolog.ro
Advancements of immunotherapy in gastrointestinal cancers: a review of clinical evidence
  • 1 Jan 2025
  • Oncolog-Hematolog.ro
Standards of the International Society of Oncology Practice Pharmacy (ISOPP) – selection of main aspects
  • 1 Jan 2025
  • Oncolog-Hematolog.ro
Renal cancer: from biological heterogeneity to clinical decision-making
  • 1 Jan 2026
  • Oncolog-Hematolog.ro
Redefining the timing of palliative care initiation in advanced and metastatic cancer: from prognostic thresholds to needs-based concurrent integration along the therapeutic trajectory
  • 1 Jan 2026
  • Oncolog-Hematolog.ro
Application of CRISPR-Cas9 technology in the treatment of chronic lymphocytic leukemia with P53 gene mutations
  • 1 Jan 2026
  • Oncolog-Hematolog.ro
Title not available
  • 1 Jan 2025
  • Oncolog-Hematolog.ro
Advancements of immunotherapy in gastrointestinal cancers: a review of clinical evidence
  • 1 Jan 2025
  • Oncolog-Hematolog.ro
Standards of the International Society of Oncology Practice Pharmacy (ISOPP) – selection of main aspects
  • 1 Jan 2025
  • Oncolog-Hematolog.ro

FAQs on Oncolog-Hematolog.ro